Oropharyngeal cancer

A new study has found that the level of a person’s immune cells may provide an indication of whether they would benefit from chemotherapy in oropharyngeal cancer.

A new test designed to classify tonsil and throat cancers into one of two groups should help deliver the right treatment to the right patients.

Rates of oropharangeal cancer have increased by around 50 per cent in the last 20 years, according to a report in the British Medical Journal.

New evidence has been found that links the spread of human papillomavirus (HPV) through oral sex with some throat cancers in both men and women.